NALP1 (NLRP1) Human shRNA Plasmid Kit (Locus ID 22861)

Specifications

Product Data
Product Name	NALP1 (NLRP1) Human shRNA Plasmid Kit (Locus ID 22861)
Locus ID	22861
UniProt ID	Q9C000
Synonyms	AIADK; CARD7; CIDED; CLR17.1; DEFCAP; DEFCAP-L/S; JRRP; MSPC; NAC; NALP1; PP1044; SLEV1; VAMAS1
Vector	pRS
Format	Retroviral plasmids
Kit Components	NLRP1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 22861). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free.
RefSeq	NM_001033053, NM_014922, NM_033004, NM_033005, NM_033006, NM_033007, NM_001033053.1, NM_001033053.2, NM_033007.1, NM_033007.2, NM_033007.3, NM_033004.1, NM_033004.2, NM_033004.3, NM_014922.1, NM_014922.2, NM_014922.3, NM_014922.4, NM_033006.1, NM_033006.2, NM_033006.3, BC051787, BC051787.1, NM_033007.4, NM_033004.4, NM_014922.5, NM_033006.4, NM_001033053.3
Summary	This gene encodes a member of the Ced-4 family of apoptosis proteins. Ced-family members contain a caspase recruitment domain (CARD) and are known to be key mediators of programmed cell death. The encoded protein contains a distinct N-terminal pyrin-like motif, which is possibly involved in protein-protein interactions. This protein interacts strongly with caspase 2 and weakly with caspase 9. Overexpression of this gene was demonstrated to induce apoptosis in cells. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the biological validity of some variants has not been determined. [provided by RefSeq, Jul 2008]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.